Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05685485 · ClinicalTrials.gov registry record

Tied Tube Trial in Glaucoma Surgery

A clinical trial of Glaucoma Eye and Ahmed Glaucoma Valve Implantation, sponsored by Washington University School of Medicine.

Recruiting
Registry status
152
Enrollment target
1
Study location

NCT05685485 is a study of Glaucoma Eye and Ahmed Glaucoma Valve Implantation that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 152 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05685485, a study of Glaucoma Eye and Ahmed Glaucoma Valve Implantation, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
152 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.

Interventions

  • PROCEDURE Standard Implantation
  • PROCEDURE Tied off Tube

Study Locations (1)

Missouri

  • Washington University - St Louis

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2022-10-18
Est. Completion 2025-01-31

What the Registry Record Tells You About NCT05685485

The ClinicalTrials.gov registry entry for NCT05685485 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glaucoma Eye appearing as the primary indexed condition, and to 2 interventions - of which Standard Implantation is the first listed.

NCT05685485 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05685485 about?

NCT05685485 is a clinical study titled "Tied Tube Trial in Glaucoma Surgery". The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at Wash...

What is the current status of trial NCT05685485?

This trial is currently recruiting. The enrollment target is 152 participants. The study started on 2022-10-18. Estimated completion is 2025-01-31.

What conditions does trial NCT05685485 study?

This clinical trial studies the following conditions: Glaucoma Eye, Ahmed Glaucoma Valve Implantation.

What interventions are being tested in trial NCT05685485?

The interventions under investigation include: Standard Implantation (PROCEDURE), Tied off Tube (PROCEDURE).

Who is sponsoring clinical trial NCT05685485?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05685485 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.